Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Share Price
Equities
300760
CNE100003G67
Advanced Medical Equipment & Technology
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 159.60 CNY | +0.47% |
|
-0.44% | -16.20% |
| 31/03 | Mindray Bio-Medical 2025 Profit Falls 30%, Revenue Slips 9% | MT |
| 30/03 | Shenzhen Mindray Bio-Medical Electronics' 2025 net profit down 30.3% Y/Y | RE |
| Capitalization | 19TCr 2.83TCr 2.41TCr 2.21TCr 2.09TCr 3.86TCr 2,65200Cr 3.95TCr 26TCr 10TCr 1,27000Cr 11TCr 10TCr 4,50700Cr | P/E ratio 2026 * |
22.4x | P/E ratio 2027 * | 18.8x |
|---|---|---|---|---|---|
| Enterprise value | 17TCr 2.53TCr 2.16TCr 1.98TCr 1.88TCr 3.46TCr 2,37700Cr 3.54TCr 23TCr 9.18TCr 1,13900Cr 9.51TCr 9.31TCr 4,04000Cr | EV / Sales 2026 * |
4.82x | EV / Sales 2027 * | 4.17x |
| Free-Float |
42.59% | Yield 2026 * |
2.79% | Yield 2027 * | 3.49% |
| 1 day | +0.47% | ||
| 1 week | -0.44% | ||
| Current month | -3.07% | ||
| 1 month | -5.85% | ||
| 3 months | -17.52% | ||
| 6 months | -27.52% | ||
| Current year | -16.20% |
| 1 week | 154.6 |  | 161.81 |
| 1 month | 154.6 | | 171.49 |
| Current year | 154.6 | | 214.12 |
| 1 year | 154.6 | | 257 |
| 3 years | 154.6 | | 351.6 |
| 5 years | 154.6 | | 502 |
| 10 years | 58.56 | | 503.51 |
| Manager | Title | Age | Since |
|---|---|---|---|
Hao Wu
CEO | Chief Executive Officer | 54 | 17/11/2020 |
Yun Zhao
DFI | Director of Finance/CFO | 43 | 15/11/2019 |
Yan Mei Guo
PRN | Corporate Officer/Principal | 63 | 27/04/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Hang Xu
CHM | Chairman | 64 | 25/01/1999 |
Xi Ting Li
CHM | Chairman | 75 | 18/12/2001 |
Ming He Cheng
BRD | Director/Board Member | 65 | 05/01/2017 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.47% | -0.44% | -27.32% | -47.06% | 2.82TCr | |
| -2.02% | -3.33% | +18.23% | -10.09% | 19TCr | |
| +7.16% | +3.26% | +1.02% | +61.09% | 16TCr | |
| -5.40% | -7.12% | -4.18% | -27.20% | 14TCr | |
| +8.99% | +0.40% | -31.75% | +26.92% | 8.85TCr | |
| -3.13% | -3.83% | -17.66% | -33.97% | 4.99TCr | |
| +2.28% | +4.26% | +15.48% | -5.79% | 4.6TCr | |
| -1.33% | +0.58% | +17.18% | -13.02% | 3.45TCr | |
| -1.22% | -2.90% | +15.78% | -17.46% | 3.3TCr | |
| -0.25% | +2.51% | +1.11% | +8.95% | 3.29TCr | |
| Average | -0.00% | -0.51% | -1.21% | -5.76% | 8.06TCr | |
| Weighted average by Cap. | -0.27% | -0.70% | +0.67% | +3.03% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.59TCr 525.44Cr 448.35Cr 411.25Cr 388.97Cr 717.8Cr 49TCr 733.73Cr 4.83TCr 1.9TCr 24TCr 1.97TCr 1.93TCr 84TCr | 4TCr 586.04Cr 500.07Cr 458.68Cr 433.83Cr 800.6Cr 55TCr 818.36Cr 5.39TCr 2.12TCr 26TCr 2.2TCr 2.15TCr 93TCr |
| Net income | 841.71Cr 123.3Cr 105.21Cr 97Cr 91Cr 168.44Cr 12TCr 172.17Cr 1.13TCr 446.41Cr 5.54TCr 462.44Cr 452.93Cr 20TCr | 1.04TCr 151.83Cr 129.56Cr 118.84Cr 112.4Cr 207.42Cr 14TCr 212.02Cr 1.4TCr 549.73Cr 6.82TCr 569.47Cr 557.75Cr 24TCr |
| Net Debt | -2TCr -292.9Cr -249.93Cr -229.24Cr -216.83Cr -400.13Cr -27TCr -409.01Cr -2.69TCr -1.06TCr -13TCr -1.1TCr -1.08TCr -47TCr | -2.63TCr -385.95Cr -329.33Cr -302.08Cr -285.71Cr -527.25Cr -36TCr -538.95Cr -3.55TCr -1.4TCr -17TCr -1.45TCr -1.42TCr -62TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 22/26/22 | 159.60 ¥ | +0.47% | 70,47,162 |
| 21/26/21 | 158.85 ¥ | +0.47% | 79,92,842 |
| 20/26/20 | 158.10 ¥ | +0.86% | 91,23,293 |
| 17/26/17 | 156.75 ¥ | -2.31% | 89,17,087 |
| 16/26/16 | 160.46 ¥ | +0.10% | 54,49,317 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 300760 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition